Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
Rokaya O Amara,1,2 Alyaa A Ramadan,1 Riham M El-Moslemany,1 Maha M Eissa,3 Mervat Z El-Azzouni,3 Labiba K El-Khordagui1 1Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt; 2Biotechnology Research Center, Tripoli, Libya; 3Department of Medical Parasitology, F...
Guardado en:
Autores principales: | Amara RO, Ramadan AA, El-Moslemany RM, Eissa MM, El-Azzouni MZ, El-Khordagui LK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9bffa63920104174bc8802474cad48bb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
por: Dkhi,Mohamed A
Publicado: (2014) -
QUETOTAXIA CERCARIANA DE LA CEPA CARABALLEDA DE Schistosoma mansoni
por: PINO,LUZ A., et al.
Publicado: (1998) -
Prevalence of Schistosoma mansoni infection among children in Ethiopia: a systematic review and meta-analysis
por: Habtye Bisetegn, et al.
Publicado: (2021) -
Daily rhythms in gene expression of the human parasite Schistosoma mansoni
por: Kate A. Rawlinson, et al.
Publicado: (2021) -
Robust Immune Response Induced by Schistosoma mansoni TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles
por: Barbosa MMF, et al.
Publicado: (2021)